New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections

Autor:	M, Chumbita, P, Monzo-Gallo, C, Lopera-Mármol, T F, Aiello, P, Puerta-Alcalde, C, Garcia-Vidal
Rok vydání:	2022
Předmět:	Microbiology (medical) Pharmacology Tazobactam Microbial Sensitivity Tests General Medicine Ceftazidime Cephalosporins Anti-Bacterial Agents Drug Combinations Drug Resistance Multiple Bacterial Gram-Negative Bacteria Pseudomonas aeruginosa Humans Gram-Negative Bacterial Infections
Zdroj:	Revista Española de Quimioterapia. 35:51-53
ISSN:	1988-9518 0214-3429
DOI:	10.37201/req/s03.12.2022
Popis:	Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251811bfe7b8e10a3667047502a6baa7 https://doi.org/10.37201/req/s03.12.2022 Zobrazit plný text záznamu